IMPACT OF GLP-1 RECEPTOR AGONIST ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: INSIGHTS FROM A LARGE-SCALE COHORT STUDY

被引：0
|
作者：
Niu, Chengu
Zhang, Jing
Arutla, Venkat
Zhu, Kaiwen
Malik, Sheza
Okolo, Patrick
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1826
引用
收藏
页码：S1424 / S1425
页数：2
相关论文
共 50 条
  • [21] Perfectionism, psychosocial impact and coping with irritable bowel disease: A study of patients with Crohn's disease and ulcerative colitis
    Flett, Gordon L.
    Baricza, Christine
    Gupta, Anita
    Hewitt, Paul L.
    Endler, Norman S.
    JOURNAL OF HEALTH PSYCHOLOGY, 2011, 16 (04) : 561 - 571
  • [22] Reassessing the Impact of Coffee Consumption on Liver Disease: Insights from a Large-Scale Cohort Study with IPTW Adjustment
    Yang, Keungmo
    Chang, Young
    Jeong, Soung Won
    Jang, Jae Young
    Ryu, Tom
    NUTRIENTS, 2024, 16 (13)
  • [23] Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn's disease and ulcerative colitis
    Bathe, Anna Luisa
    Mavropoulou, Eirini
    Mechie, Nicolae-Catalin
    Petzold, Golo
    Ellenrieder, Volker
    Kunsch, Steffen
    Amanzada, Ahmad
    PLOS ONE, 2019, 14 (10):
  • [24] Patterns of Extraintestinal Manifestations in Ulcerative Colitis and Crohn's Disease: Results From a Large Cross-Sectional Cohort
    Koh, Joyce M.
    Limketkai, Berkeley N.
    Parian, Alyssa M.
    Brant, Steven R.
    Bitton, Alain
    Cho, Judy H.
    Duerr, Richard H.
    McGovern, Dermot P.
    Proctor, Deborah D.
    Regueiro, Miguel
    Rioux, John D.
    Schumm, L. Philip
    Taylor, Kent D.
    Silverberg, Mark S.
    Steinhart, A. Hillary
    Lazarev, Mark
    GASTROENTEROLOGY, 2013, 144 (05) : S615 - S615
  • [25] THE IMPACT OF INTERMEDIATE TITER ANTIBODIES TO ADALIMUMAB (ATA) AND INFLIXIMAB (ATI) ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE (CD) OR ULCERATIVE COLITIS (UC)
    Wang, Chaoyang
    Tolaymat, Mazen
    Cross, Raymond
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S57 - S57
  • [26] THE IMPACT OF INTERMEDIATE TITER ANTIBODIES TO ADALIMUMAB (ATA) AND INFLIXIMAB (ATI) ON CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE (CD) OR ULCERATIVE COLITIS (UC)
    Wang, Chaoyang
    Tolaymat, Mazen
    Cross, Raymond
    GASTROENTEROLOGY, 2021, 160 (03) : S77 - S78
  • [27] Genotypic Overlap Between Crohn's Disease (CD) and Ulcerative Colitis (UC) in a Large Cohort of Patients With Inflammatory Bowel Disease (IBD)
    Waterman, Matti
    Stempak, Joanne M.
    Kabakchiev, Boyko
    Xu, Wei
    Griffiths, Anne M.
    Greenberg, Gordon R.
    Steinhart, Hillary
    Silverberg, Mark S.
    GASTROENTEROLOGY, 2010, 138 (05) : S678 - S678
  • [28] Pregnancy Outcomes in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis: Results From the Ozanimod Clinical Development Program
    Dubinsky, Marla C.
    Charles, Lorna
    Selmaj, Krzysztof W.
    Comi, Giancarlo
    Krakovich, Anthony
    Rosen, Melissa
    Van Der Woude, C. Janneke
    Mahadevan, Uma
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S2 - S3
  • [29] A Historical Cohort Study Comparing the Clinical Outcome of Ulcerative Colitis and Crohn's Disease in the Presence of Primary Sclerosing Cholangitis
    Navaneethan, Udayakumar
    Venkatesh, Preethi G. K.
    Lashner, Bret
    Remzi, Feza H.
    Kiran, Pokala R.
    Shen, Bo
    Fung, John J.
    GASTROENTEROLOGY, 2012, 142 (05) : S40 - S40
  • [30] Comparision of Cardiovascular Outcomes Between Crohn's Disease and Ulcerative Colitis -A Retrospective Review from a Large Inpatient Sample!
    Chennapragada, Suma Sri
    Sheth, Aakash R.
    Garikipati, Subhash
    Patel, Kirtenkumar
    Patel, Harsh
    Samant, Hrishikesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1372 - S1373
12345